Acrivon Therapeutics Current Assets

Acrivon Therapeutics (ACRV) currently reports a current assets of $91M as of June 2026. That compares with $140M in the prior-year period — down 33.9% year over year. Use the charts on this page to explore Acrivon Therapeutics's current assets history and peer comparisons.

Acrivon Therapeutics's current assets decreased from $140M to $91M — a 33.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acrivon Therapeutics reported $91M in current assets as of June 2026. That compares with $140M in the prior-year period — down 33.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $91M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acrivon Therapeutics, and consider following ACRV for alerts when major investors trade the stock.